semaglutide skin pain Side Effects: Sensitivity and Injection Site Reactions Side Effects of Semaglutide

The key difference between the two drugs is that Ozempic is designed for treatment of type 2 diabetes at doses of 0.5 to 1 mg weekly, while Wegovy has been FDA-approved as a weight loss drug with a weekly dosage of 2.4 mg

One participant with a placebo developed severe hypoglycemia due to CGM malfunction

PlexusDx is also cash-pay with no membership and no insurance billing

Compound Receptors Peak trial weight loss Lean mass as share of loss Semaglutide (Ozempic/Wegovy) GLP-1 ~14.9% (STEP-1, 68 wk) ~39% Tirzepatide (Mounjaro/Zepbound) GLP-1 + GIP ~20.9% (SURMOUNT-1, 72 wk) ~25-40% Retatrutide GLP-1 + GIP + GCGR ~24.2% (Phase 2, 48 wk) Comparable class range Best for understanding the takeaway: the percentage of loss that is lean mass is roughly constant across the class

In clinical trials, average participants experienced 10-15% weight reductions of their initial body weight

Arjona Ferreira, J